CLS B — Clinical Laserthermia Systems AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK60.30m
- SEK34.98m
- SEK18.78m
Annual cashflow statement for Clinical Laserthermia Systems AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | PRESS | Interim Report | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | — | 0 | 0.073 | 0.304 | 0.238 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -54.4 | -66.1 | -68.1 | -66.5 | -56.5 |
| Capital Expenditures | -0.546 | -0.508 | -0.562 | -5.5 | -7.47 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.038 | 0.147 | -0.324 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.508 | -0.361 | -0.886 | -5.5 | -7.47 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 62 | 85.9 | 48.5 | 76.7 | 71.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.1 | 19.4 | -20.6 | 4.74 | 7.17 |